Ascendis Pharma A/S (ASND)
225.00
-5.21
(-2.26%)
USD |
NASDAQ |
Feb 20, 16:00
225.74
+0.74
(+0.33%)
After-Hours: 20:00
Ascendis Pharma Profit Margin (Quarterly) : -13.56% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk A/S | 33.98% |
| Evaxion AS | -- |
| DBV Technologies SA | -- |
| Cellectis SA | 1.67% |
| Biodexa Pharmaceuticals Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -19.44% |
| Return on Invested Capital | -33.58% |
| Gross Profit Margin (Quarterly) | 88.91% |
| Operating Margin (Quarterly) | 4.00% |
| Return on Net Operating Assets | -39.79% |